Introduction
Adult T-cell leukemia (ATL) is a peripheral CD4 + T cell neoplasm caused by human T-cell leukemia virus type 1 (HTLV-1). 1,2 HTLV-1 is primarily transmitted during the neonatal period through breast feeding from HTLV-1 carriers and approximately 5% of HTLV-1 carriers develop ATL decades after the initial infection. A recent report showed that multiple subclones with various chromosomal gain or loss originate as a result of clonal evolution, 3 suggesting longitudinal accumulations of genetic abnormalities in host genome are required for the development of ATL.
These abnormalities have been thought to accumulate in some specific populations with longevity such as hematopoietic stem cells (HSCs) and to consequently transform normal stem cells into cancer stem cells such as leukemia initiating cells (LICs) in myeloid malignancies. 4, 5 However, since lymphocytes generally have a long life span, it remains uncertain whether lymphoid malignancies develop in particular populations or randomly in common mature populations. 6 The origin of ATL cells is currently unclear. Although several studies have pointed out close immunophenotypic and functional resemblances between ATL cells and regulatory T cells, 7-9 a recent paper noted that such features can be acquired or induced by virus molecules but not inherited from the initially infected T cells. 10 In Tax-transgenic mice, CD117  + hematopoietic progenitor cells recapitulated T cell lymphoma. 11 These findings raise the possibility that the initial ATL clones might originate in a clinically disregarded population rather than the major population with conventional phenotypes.
For personal use only. on . by guest www.bloodjournal.org From cells. This population possesses stem cell-like properties including enhanced self-renewal capacity and multipotency to generate T CM and T EM cells, 12 and it appears to support long-lived T cell memory against viruses. 13 As many cancers are organized hierarchically and sustained by a rare subpopulation with self-renewal capacity at the apex of the hierarchy, 14 we investigated the phenotypic and functional heterogeneity and the hierarchy of ATL cells and whether the T SCM population is involved in the development of ATL.
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Materials and methods
Clinical samples
This study was approved by the institutional review board of Graduate School of Medicine, Kyoto University and abided by the tenets of the Declaration of Helsinki. All specimens from healthy individuals (HIs), HTLV-1 carriers, and ATL patients were collected after written Table S1 .
Flow cytometric analysis and sorting
Mononuclear cells from peripheral blood (PBMCs) or bone marrow (BMMCs) were purified using Ficoll-Paque PLUS (GE Healthcare Bio-sciences AB). We isolated CD4 + T cell subpopulations according to a previously described protocol 12, 16 with minor modifications.
Because CD3 often declines aberrantly and CD25 is a crucial marker in ATL and CD62L is typically positive in the CD45RA + CCR7 + population, lineage markers such as CD11b, CD14, and CD56 were used instead of CD3 to exclude other CD4 + populations including dendritic cells, monocytes, and natural killer cells, and CD62L was skipped instead of adding CD25. Thus
PBMCs were stained with anti-CD45RO, anti-CCR7, anti-CD95, anti-CD122, anti-CD25, anti-CD4, and anti-CD45RA, in addition to a cocktail including anti-CD11b, anti-CD14, and BMMCs were stained with anti-CD34,   anti-CD38, and lineage cocktail including anti-CD3, anti-CD4, anti-CD8, anti-CD11b, anti-CD14, anti-CD19, anti-CD20, anti-CD56, and anti-Glycophorin A. Antibodies list is shown in Table S2 . Analyses and sorting were performed with FACS Aria II Special Order System and Diva software (Becton Dickinson Biosciences) or FlowJo software (Tomy Digital Biology).
PCR for HTLV-1 provirus, inverse long PCR, and ATL clone-specific PCR
Genomic DNA was isolated with QIAamp DNA Mini or Micro Kit (QIAGEN, Tokyo, Japan).
Qualitative and quantitative PCR were performed for the pX region which is relatively conserved in the HTLV-1 genome, and RNase P as the internal control, with Ex-Taq Hot Start Version or SYBR Premix Ex Taq II and the TaKaRa Thermal Cycler Dice (TP800) (Takara, Shiga, Japan).
After normalizing the value of pX to that of RNase P (pX/RNase P) in each sample, HTLV-1 proviral load (PVL) was described as the relative value of pX/RNase P to that in the human genome adjacent to the provirus integration site in each case. Primers and PCR conditions used in these assays are shown in Table S3 .
In vitro assay
Each sorted population was labeled with carboxyfluorescein succinimidyl ester (CFSE, Biotium) as previously described. 18 In brief, cells were labeled with 5 μM CFSE for 10 minutes at room temperature in PBS supplemented with 5% heat inactivated fetal bovine serum (FBS, Sigma-Aldrich), and washed three times. Subsequently, twenty thousand cells were suspended in Iscove's modified Dulbecco's medium (IMDM, GIBCO) supplemented with 20% FBS, 100 μg/ml primocin (InvivoGen), and 25 ng/ml recombinant human interleukin 7 (IL-7) (PeproTech).
Cells were then plated in 96-well U-Bottom plates and incubated at 37°C in a humidified 5% intraperitoneally into 6-10 week-old NOG, NSG or NRG mice. NOG and NSG mice were irradiated (150 cGy) 1 day prior to inoculation. Peripheral blood cells were analyzed at indicated time points for the repopulation and phenotype of repopulating human cells. Finally mice were sacrificed 6-12 weeks after transplantation, and cells from peripheral blood and spleen were analyzed with regard to chimerisms, phenotype, and clonality.
Statistical analysis
Statistical analyses were performed using GraphPad Prism 6 (GraphPad Software Inc). Three or more groups were compared with Kruskal-Wallis test followed by Dunn's multiple comparisons test. P < .05 was considered to indicate statistical significance.
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Results
No existence of HTLV-1-infected cells in hematopoietic stem and progenitor populations
We first investigated if hematopoietic stem and progenitor cells (HSPCs) were infected with HTLV-1. We obtained BMMCs from five ATL patients (Table S1) Next we applied the same gating method to PBMCs from 3 HTLV-1 carriers and 17 ATL patients and found that all four populations were separable across all disease phases (Figure 2A and S1; Table S4 HIs and ATL patients, although increased in some acute type ATL cases. We were also concerned that tax expression might drive the expansion of T SCM , T CM , and T EM populations in patients. However, tax expression level was very low in many cases and not correlated to cell numbers of any population ( Figure S4C ). Finally we analyzed CD25 expression which is a key marker of ATL cells, to roughly estimate the occupancy of ATL cells in each population ( Figure   S5A ; Table S5 
Existence of ATL clones not only in T CM and T EM populations but also in the T SCM population
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ATL is generally composed of only one or a few dominant clones among numerous HTLV-1-infected cells, raising the possibility that the distribution of ATL clones may differ from that of HTLV-1-infected cells. We then investigated HTLV-1 integration sites. Inverse long PCR showed the single product in all tested cases excluding one case (Pt-7), indicating that Pt-7 was supposed to be oligoclonal but all other cases had monoclonal expansion ( Figure S7A ).
Based on sequencing data of these single products ( Figure S7B ), we constructed ATL clone-specific PCR which amplified the unique flanking region of HTLV-1 integration site in each case (Table S3) . We then examined the presence of the ATL clone in each sorted population from ATL patients. In all tested cases, each targeted site was amplified not only in T CM and T EM cells but also in T SCM cells, while no amplification was detected in T N cells ( Figure   3D ). Even in T SCM cells from Pt-6 with a low value of PVL (1.3 copies/100cells), the ATL clone-specific HTLV-1 integration site was clearly amplified. This result indicates that ATL clones are also phenotypically heterogeneous and clearly exist in the T SCM population.
Unidirectional differentiation of T SCM cells to T CM and T EM cells in ATL
The successful demonstration of phenotypic heterogeneity of HTLV-1-infected cells and ATL clones encouraged us to investigate the possibility of functional hierarchy; namely, that T SCM cells are upstream of T CM and T EM cells in HTLV-1 carriers and ATL patients. We highly purified each memory T cell population ( Figure 4A ) and performed an in vitro culture assay with IL-7 which promotes survival but not differentiation of CD4 + T cells. 27 In a case of HI, each sorted population This data is consistent with the increase of PVL that was 3.4 copies/100cells in T SCM , 34.3 copies/100cells in T CM , and 68.0 copies/100cells in T EM cells (Table S6 ). Such increase in PVL from T SCM to T CM and T EM cells was validated in many other cases, regardless of disease phases ( Figure 3B ). These data demonstrate the existence of unidirectional alteration from T SCM to T CM and T EM cells, which contributes to expansion of the HTLV-1-infected T cell pool.
High repopulating capacity of T SCM cells in ATL
To validate the hierarchy demonstrated in vitro assay and further assess the tumorigenicity of T SCM cells from ATL patients in vivo, we conducted a xenogeneic transplantation assay. We The identical ATL clone was clearly detected in one (S22) of two mice transplanted with T SCM cells ( Figure S8C ). Notably, PVL in the T SCM populations was very low, 17.1 copies/100cells in Pt-4 and only 1.3 copies/100cells in Pt-6 (Table S6) For
Discussion
In this study, we have provided the new concept of the hierarchical architecture of ATL. First, we examined how upstream ATL clones can be phenotypically traced. Several recent studies have challenged the conventional belief that mature lymphocytes are the origin of lymphoid malignancies. For instance, tumor development appears to be initiated in HSPCs in certain mature lymphoid malignancies, including chronic lymphocytic leukemia (CLL), 28, 29 angioimmunoblastic T cell lymphoma, 30 and hairy cell leukemia. 31 Moreover, the identification of the T SCM population with stem cell-like features 12, 13 has produced the new concept that the T SCM population is a reservoir of another retrovirus, HIV-1. 32 Based on these findings, we lymphocytosis which is a pre-leukemia phase of CLL in a xenogeneic model. 28 In acute myeloid leukemia, the clone which has only a first hit is detected in HSCs but the clone with a secondary hit is generated in progenitor levels. 39 Given these reports, it is noteworthy in understanding clonal evolution of ATL that the repopulating capacity of T SCM could be observed in early phase of ATL such as smoldering cases although we unfortunately could not perform xenotransplantation assay of acute type ATL cases due to the sample limitation. Taken together, our data suggest that T SCM cells could be a candidate of ATL initiating or pre-leukemia stem cells.
The current study has not focused on whether the T SCM population is a direct target for HTLV-1 infection. Although our in vitro data showed the susceptibility of T SCM cells to HTLV-1 
